Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bahra

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2014
SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 studyM Sinn, B V Sinn, J K Striefler, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final resultsM Sinn, T Liersch, H Riess, et al.
Annals of Surgery|July 3, 2015
Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767): Perioperative and Long-term Results of a Multicenter Randomized Controlled TrialTobias Keck, U F Wellner, M Bahra, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2014
SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 studyM Sinn, B V Sinn, J K Striefler, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final resultsM Sinn, T Liersch, H Riess, et al.
Annals of Surgery|July 3, 2015
Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767): Perioperative and Long-term Results of a Multicenter Randomized Controlled TrialTobias Keck, U F Wellner, M Bahra, et al.
Pageof 5